As more details of the Trump administration’s fiscal plans for the year ahead come to light, so do more thinly veiled attacks on cannabis, this time the ongoing cannabis rescheduling process.
President Joe Biden has officially confirmed that cannabis is set to be rescheduled from a Schedule I substance to a Schedule III.
The Biden administration is relying heavily on cannabis reform to drum up support among younger voters ahead of the upcoming presidential election.
A decision from the US Drug Enforcement Agency (DEA) on cannabis rescheduling is 80% likely to come in the next few months, according to new analysis.
Numerous sources have suggested that a decision from the US Drug Enforcement Agency (DEA) on cannabis rescheduling could be ‘imminent’, but these claims have been denied by the government spokespeople.
The US Secretary for the Department of Health and Human Services (HHS) Xavier Becerra has said he believes the hotly anticipated cannabis scheduling review will be completed ‘this year’.
Two new bills — one aimed at expunging criminal records, the other at regulating CBD in food and drinks — show cannabis reform, unlike nearly every other issue facing Americans, is backed by both Republicans and Democrats.
The US House of Representatives passed the SAFE Banking Act for the fifth time this week, this time attached to defense spending legislation that some key players say could mean it actually makes it through the Senate this time.
Senators Chuck Schumer, Cory Booker and Ron Wyden held a press conference yesterday to introduce their draft bill of the Cannabis Administration and Opportunity Act.
